Oligonucleotide-based therapeutics

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Nature

• Publication date

  1991-04-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1038/350442A0
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Modified deoxyoligonucleotides stable to exonuclease degradation in serum.

  1991cited by this paper
• In vitro selection of RNA molecules that bind specific ligands

  1990cited by this paper
• Sequence-specific DNA binding by the c-Myc protein.

  1990cited by this paper
• Differences and similarities in DNA-binding preferences of MyoD and E2A protein complexes revealed by binding site selection.

  1990cited by this paper
• Deoxyoligonucleotide analogs based on formacetal linkages

  1990cited by this paper
• Sequence-specific alkylation of double-helical DNA by oligonucleotide-directed triple-helix formation

  1990cited by this paper
• Recognition of mixed-sequence duplex DNA by alternate-strand triple-helix formation

  1990cited by this paper
• Antisense oligonucleotides: a new therapeutic principle

  1990cited by this paper
• Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase.

  1990cited by this paper
• Inhibition of DNA binding proteins by oligonucleotide-directed triple helix formation.

  1989cited by this paper
• Sequence-specific cleavage of double helical DNA by triple helix formation.

  1987cited by this paper
• Injected anti-sense RNAs specifically block messenger RNA translation in vivo.

  1985cited by this paper
• Inhibition of thymidine kinase gene expression by anti-sense RNA: a molecular approach to genetic analysis.

  1984cited by this paper

• Versatility of peptide nucleic acids (PNAs): role in chemical biology, drug discovery, and origins of life

  2017cites this paper
• One‐Shot Immunomodulatory Nanodiamond Agents for Cancer Immunotherapy

  2016cites this paper
• Compounds with p-Block Elements

  2016cites this paper
• Pharmaceutical Biotechnology: The Arrival of Recombinant Proteins

  2015cites this paper
• DNA aptamers selected against wild-type helix 69 ribosomal RNA and their implications in combating antibiotic resistance

  2015cites this paper
• Spectroscopic Study on the Effect of Imidazophenazine Tethered to 5′-End of Pentadecathymidilate on Stability of Poly(dA)·(dT)15 Duplex

  2012cites this paper
• Oral Delivery of Nucleic Acid Drugs

  2009cites this paper
• Perspectivesin CancerResearch Acquired Immunodeficiency Syndrome and Non-Hodgkin's Lymphomas

  2006cites this paper
• Electrospray ionization mass spectra of dinucleotide N3 '-> P5 ' phosphoramidates

  2005cites this paper
• Raman study of potential "antisense" drugs: nonamer oligonucleotide duplexes with a central mismatch as a model system for the binding selectivity evaluation.

  2004cites this paper
• Nucleic acid drugs: a novel approach

  2004cites this paper
• Pharmacokinetics of a tumor necrosis factor-alpha phosphorothioate 2'-O-(2-methoxyethyl) modified antisense oligonucleotide: comparison across species.

  2003cites this paper
• Binding of aminoglycoside antibiotics with modified A-site 16S rRNA construct containing non-nucleotide linkers.

  2002cites this paper
• Antisense Oligonucleotide Sequences Targeting the Muscarinic Type 2 Acetylcholine Receptor Enhance Performance in the Morris Water Maze

  2000cites this paper
• Antisense and nuclear medicine.

  1999cites this paper
• Raman spectroscopic study of triplex‐like complexes of polyuridylic acid with the isopolar, non‐isosteric phosphonate analogues of diadenosine monophosphate

  1999cites this paper
• UV spectroscopy study on complexes of phosphonate ApA analogs with poly(U): promising step in prediction of oligonucleotide analog properties?

  1998cites this paper
• Zwitterionic oligodeoxyribonucleotide N3'-->P5' phosphoramidates: synthesis and properties.

  1998cites this paper
• 7‐Deazaguanine DNA: Oligonucleotides with hydrophobic or cationic side chains

  1997cites this paper
• Chemical physics of solid-state nucleic acids: new intriguing horizons

  1997cites this paper
• Diastereoselective Synthesis of 2′-Deoxy and 2′-O-Methyl Dinucleoside (3′ 5′)-Methylphosphonates via Alkoxymagnesium Chloride-Mediated Nucleoside Coupling

  1997cites this paper
• In vitro selection of optimal AbrB‐binding sites: comparison to known in vivo sites indicates flexibility in AbrB binding and recognition of three‐dimensional DNA structures

  1996cites this paper
• Triple helix-forming oligodeoxyribonucleotides targeted to the human tumor necrosis factor (TNF) gene inhibit TNF production and block the TNF-dependent growth of human glioblastoma tumor cells.

  1996cites this paper
• Dielectric response of triplex DNA in ionic solution from simulations.

  1995cites this paper
• Bio-affinity characterization mass spectrometry.

  1995cites this paper
• Large-scale oligonucleotide synthesizers

  1995cites this paper
• Design and development of sequence selective lexitropsin DNA minor groove binders

  1995cites this paper
• [41] Selection of protein binding sites from random nucleic acid sequences

  1995cites this paper
• Nucleic Acids and Molecular Biology

  1994cites this paper
• Allogeneic bone marrow transplantation.

  1994cites this paper
• The new frontier: gene and oligonucleotide therapy.

  1994cites this paper
• Targeting radiation to tumours.

  1994cites this paper
• Detection and characterization of triple-helical pyrimidine-purine-pyrimidine nucleic acids with vibrational circular dichroism.

  1994cites this paper
• A database of 32 DNA triplets to study triple helices by molecular mechanics and dynamics.

  1994cites this paper
• Electrostatic effects in DNA triple helices.

  1994cites this paper
• Stability of peptide nucleic acids in human serum and cellular extracts.

  1994cites this paper
• Oligonucleotide-Based Therapeutics of Human Malignancies

  1994cites this paper
• Isolation of RNA Aptamers for Biological Cofactors by In Vitro Selection

  1994cites this paper
• Using in vitro nucleic acid selections for conventional drug design

  1994cites this paper
• Isolierung von RNA‐Aptameren für biologische Cofaktoren durch In‐vitro‐Selektion

  1994cites this paper
• Receptor-based assays.

  1993cites this paper
• The discovery and characterization of a novel nucleotide-based thrombin inhibitor.

  1993cites this paper
• Modulation of human prorenin gene expression by antisense oligonucleotides in transfected CHO cells.

  1993cites this paper
• Selection and design of high-affinity RNA ligands for HIV-1 Rev.

  1993cites this paper
• Biotechnology in the drug discovery process: Strategic and management issues

  1993cites this paper
• 4 – Antibody Targeting

  1993cites this paper
• Lexitropsins in antiviral drug development.

  1992cites this paper
• The pathogenesis of AIDS lymphomas: a foundation for addressing the challenges of therapy and prevention.

  1992cites this paper
• IN-VITRO-SELEKTION SPEZIFISCH LIGANDENBINDENDER NUCLEINSAUREN

  1992cites this paper
• Structure-Based Strategies for Drug Design and Discovery

  1992cites this paper
• In vitro genetics.

  1992cites this paper
• Selection in vitro of single-stranded DNA molecules that fold into specific ligand-binding structures

  1992cites this paper
• In Vitro Selection of Specific Ligand‐binding Nucleic Acids

  1992cites this paper
• Perspectives in CancerResearch Acquired Immunodeficiency Syndrome and Non-Hodgkin's Lymphomas

  1991cites this paper
• Solid-phase gene assembly

  1991cites this paper
• Die Medizinische Chemie im Goldenen Zeitalter der Biologie: Lehren aus der Steroid‐ und Peptidforschung

  1991cites this paper